Logo

Canada Grants C$600K for Genomics in Saskatchewan

Jul 13, 2015 | staff reporter

NEW YORK (GenomeWeb) – The Canadian government today announced it has awarded C$600,000 (US$471,102) to Genome Prairie through the Western Diversification Program to advance genomics in Saskatchewan.

The funds will be used to spur companies and organizations to adopt genomic technologies. Genome Prairie said in a statement it will develop partnerships to benefit the mining, energy, and agriculture sectors.

"With this support from the Government of Canada and Western Economic Diversification Canada, we can proactively engage with new and established companies to demonstrate tangible economic benefits that improve the quality of life for all Canadians," Genome Prairie CEO Reno Pontarollo said in a statement.

Last week, Canada provided C$1.1 million to the University of Lethbridge in Alberta to support a synthetic biology maker space.

Filed under

Research Funding
Applied Markets: Ag-Bio, Veterinary, Forensics, Food Safety, & Environmental Testing
Genome Canada
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.